Balazs Halmos
Associate Director, Clinical Science, Montefiore Einstein Comprehensive Cancer Center · Montefiore Medical Center/Albert Einstein College of Medicine
Credentials: · · · ·
History
- 1995–1998
- 1988–1992
Semmelweis Medical University, Budapest
Research
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
Case report · New England Journal of Medicine · 2005 · Last of 10 authors · 3,372 citations
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2018 · 3,041 citations
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers
Science Translational Medicine · 2012 · 1,056 citations
49 papers
23 papers
- DT
20 papers
19 papers
18 papers
- AB
17 papers
16 papers
15 papers
Grants
- 1997–2028
National Cancer Institute · P30
Project lead · $1.4M · Albert Einstein College of Medicine
- 2014–2027
Montefiore Academic Community NCORP Program
National Cancer Institute · UG1
Contact PI · $6.7M · Montefiore Medical Center (Bronx, Ny)
Clinical trials
- 2021–2023
- 2008
Lapatinib Resistance in Patients With Breast Cancer
Principal investigator · Withdrawn
Case Comprehensive Cancer Center
- 2007
Principal investigator · Withdrawn
Case Comprehensive Cancer Center